ADIM
TMDX icon

Alpha DNA Investment Management’s Transmedics TMDX Stock Holding History

Alpha DNA Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,752
Closed -$432K – 254
2024
Q3 		$432K Sell
2,752
-684
-20% -$105K 0.16% 158
2024
Q2 		$518K Sell
3,436
-3,301
-49% -$396K 0.2% 94
2024
Q1 		$498K Buy
6,737
+400
+6% +$33K 0.18% 154
2023
Q4 		$500K Buy
+6,337
New +$382K 0.2% 126

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpha DNA Investment Management's TMDX Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 2,752 shares — an estimated $432K sold.

Alpha DNA Investment Management first reported a position in TMDX in Q4 2023 and held it in 4 quarters. The position peaked at $518K in Q2 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Alpha DNA Investment Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,752 Transmedics shares in Q4 2024, an estimated $432K.
  • Alpha DNA Investment Management first reported a position in Transmedics in Q4 2023 and held it in 4 quarters.
  • Alpha DNA Investment Management's Transmedics position peaked at $518K in Q2 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.